Skip to main content

Posterior Surgery Noninferior to Anterior for Cervical Radiculopathy

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 12, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Aug. 12, 2024 -- For patients with cervical radiculopathy, posterior surgery is noninferior to anterior surgery with respect to success rate and reduction in arm pain, according to a study published online July 24 in the Journal of Bone & Joint Surgery.

Nadia F. Simões de Souza, M.D., from the University of Groningen in the Netherlands, and colleagues conducted a multicenter, noninferiority trial involving patients with single-level cervical radiculopathy in nine Dutch hospitals with two-year follow-up duration. A total of 265 patients were randomly assigned: 132 and 133 to the posterior surgery group (posterior cervical foraminotomy) and anterior surgery group (anterior discectomy with fusion), respectively. Primary outcome data were available for 236 of the 243 patients who underwent the allocated intervention.

The researchers found that the predicted proportions of a successful outcome were 0.81 and 0.74 after posterior and anterior surgery, respectively (difference in rate, −0.06 [one-sided 95 percent confidence interval, −0.02]), indicating noninferiority of the posterior group. The difference in arm pain between the groups was −2.7 (one-sided 95 percent confidence interval, 7.4), and the between-group difference in the decrease in arm pain was 1.5 (one-sided 95 percent confidence interval, 8.2), confirming noninferiority. Small between-group differences were seen in secondary outcomes. Overall, 8 and 9 percent of patients who underwent posterior and anterior surgery, respectively, had serious surgery-related adverse events (difference, −0.02; two-sided 95 percent confidence interval, −0.09 to 0.05).

"Our findings provide level-I evidence that posterior surgery is noninferior to anterior surgery with regard to the clinical outcome, with follow-up of two years," the authors write.

Several authors disclosed ties to the pharmaceutical and medical device industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Endolymphatic Sac Decompression Effective for Vertigo, Migraine

WEDNESDAY, May 28, 2025 -- For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and...

One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years

TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...

Pediatric Magnet Ingestion Rates Still High

THURSDAY, May 22, 2025 -- Global pediatric magnet ingestion rates remain high and incidence has increased, despite the implementation of national policies, according to a review...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.